secwatch.observer — SEC 8-K summary
======================================

Issuer:     ASSEMBLY BIOSCIENCES, INC. (ASMB)
CIK:        0001426800
Form:       8-K
Filed at:   2023-05-30T23:59:59+00:00
Accession:  0000950170-23-024879
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stockholders reject authorized share increase to 225M at ASMB annual meeting
----------------------------------------------------------------------------

- All eight director nominees elected with no opposition.
- Say-on-pay advisory approved (10.6M for, 1.7M against).
- Ratification of Ernst & Young as auditor for FY2023 approved (21.5M for).
- Amendment to 2018 Stock Incentive Plan increasing share reserve from 8.6M to 10.6M shares approved.
- Proposal to increase authorized common stock from 150M to 225M shares failed, limiting future equity issuance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1426800/000095017023024879/0000950170-23-024879-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1426800/000095017023024879/asmb-20230525.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-024879

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer